Pain in the back of your knee when walking? Learn the causes, symptoms, and best treatments to relieve discomfort and prevent ...

Patellofemoral pain syndrome is also called runner’s knee or jumper’s knee because it is commonly associated with athletes, though nonathletes can get it, too. While this injury is ...

Patellofemoral stress syndrome (PFSS) is a type of overuse injury that causes pain in the soft tissues and bone in the front of the knee. Also known as "runner's knee" or "jumper's knee," PFSS ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

TORCH syndrome may sound like one medical condition. But it’s actually a group of different infections. They're caused by tiny germs like bacteria, viruses, or parasites. The germs (pathogens ...

So Shiny Object Syndrome is coming home to roost there. … in this weird middle place professionally, where they’re not tech-shiny but they don’t yet often control the purse strings ...

The Food and Drug Administration approved a medication this week known as VYKAT XR to treat hyperphagia — or an incessant feeling of hunger — in kids and adults with Prader-Willi syndrome. The ...

But Walz absolutely has caught a case of “main character” syndrome. He seems to have convinced himself that he is a major player. That the Democratic party is clamoring for what he is selling.

Disease name: Trimethylaminuria (TMAU), also known as "fish odor syndrome" Affected populations: TMAU is a rare metabolic condition that causes a person to smell like rotten fish. The condition is ...

Diazoxide choline extended-release is the first FDA-approved therapy to address hyperphagia in Prader-Willi syndrome. Soleno Therapeutics announced the medication will be available beginning in April.

March 27, 2025 – The FDA has approved a drug to treat a key symptom of a rare life-threatening genetic disorder known as Prader-Willi syndrome (PWS) in adults and children ages 4 or older.

The FDA has approved Soleno Therapeutics’ Vykat XR (diazoxide choline) extended-release tablets to treat hyperphagia in individuals aged four years and older with Prader-Willi syndrome (PWS). The ...